Natalizumab Completed Phase N/A Trials for Disseminated Sclerosis

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02386566Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab
NCT00937677Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
NCT01070823JC-Virus (JCV) Antibody Program
NCT02137109Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri